Funds & Fund Managers
Where will the special dividends come from next?
Leading UK equity income managers discuss where they see special dividends as likely to appear next.
Woodford: Why AstraZeneca should reject any renewed Pfizer bid
Neil Woodford says he rates the chances of Pfizer making a renewed bid for AstraZeneca 50/50, but believes in reality, the US pharma giant ‘simply cannot afford’ to pay what its UK rival’s drug pipeline is worth.
Woodford pours £2 million into private toilet firm
Toilet system firm Propelair becomes the latest private firm represented in the CF Woodford Equity Income fund.
Hargreaves Wealth 150 shrinks to historic low on star shortage
'There is no shortage of funds available to UK investors, just a shortage of good ones,' says Hargreaves.
AAA-rated Cholwill: The election is making me avoid housebuilders
Manager sees sector coming under the same scrutiny utilities and banks have.
Serco shares crash after warning; Tesco lights up FTSE
Serco slumps by a third after the outsourcing company slashes profit forecasts, but Tesco surge helps FTSE 100 edge higher.
Invesco's Barnett: best days of the UK recovery behind us
Invesco Perpetual's head of UK equities sees outlook as ok but not spectacular.
Woodford buys four unquoted stocks
Unquoted stocks now account for more than 5% of the fund.
SGPB Hambros' Verleyen ups alternatives allocation on volatility fears
SocGen’s Eric Verleyen is running with 21% exposure to alternatives in the firm’s Balanced mandate due to concerns about volatility remaining at elevated levels.
Ben Whitmore: when is a profit not a profit?
After the furore over Tesco's earnings miscalculation, Jupiter's Citywire A-rated fund manager offers an insight into analysing company profit.